Heat shock protein-56 is induced by cardiotrophin-1 and mediates its hypertrophic effect

J E Railson1, K Lawrence, J C Buddle

  • 1Medical Molecular Biology Unit, The Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.

Insights

Cardiotrophin-1 (CT-1) induces heat shock protein 56 (hsp56) in cardiac cells. Hsp56 overexpression significantly increases cardiac cell size, demonstrating its role in CT-1-induced cardiac hypertrophy.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cell Biology
  • Cytokine Signaling

Background:

  • Cardiotrophin-1 (CT-1), an IL-6 family cytokine, exhibits protective and hypertrophic effects on the heart.
  • CT-1 upregulates heat shock proteins (HSPs) like hsp70 and hsp90, implicated in cellular protection.
  • The role of other HSPs, such as hsp56 (FKBP59), in CT-1's cardiac effects remains unclear.

Purpose of the Study:

  • To investigate the induction and functional role of heat shock protein 56 (hsp56) in CT-1-mediated cardiac hypertrophy.
  • To determine if hsp56 contributes to the hypertrophic response in primary neonatal rat cardiac myocytes.

Main Methods:

  • CT-1 treatment was used to assess hsp56 mRNA and protein expression in cardiac cells.
  • Overexpression of hsp56 was achieved using plasmid and Herpes viral vectors in neonatal rat cardiac myocytes.
  • Antisense constructs were employed to inhibit hsp56 expression and evaluate its impact on CT-1's hypertrophic effect.

Main Results:

  • CT-1 treatment significantly increased both mRNA and protein levels of hsp56.
  • Overexpression of hsp56 led to a marked increase in cardiac myocyte size and protein:DNA ratio.
  • Hsp56 knockdown using antisense constructs blocked the hypertrophic effect of CT-1, while hsp27, hsp70, and hsp90 overexpression did not affect cell size.

Conclusions:

  • Heat shock protein 56 (hsp56) is induced by Cardiotrophin-1 (CT-1) in cardiac cells.
  • Hsp56 plays a critical role in mediating CT-1-induced cardiac hypertrophy, distinct from the protective roles of hsp70 and hsp90.
  • This study identifies hsp56 as the first heat shock protein demonstrated to have a hypertrophic effect in cardiac myocytes.

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...